Ads
related to: bluebird bio stock forecast- Zacks #1 Rank
No-Obligation, Free 30-Day Trial
Sign Up Today for Zacks Premium
- Free Portfolio Tracker
Get Daily Online & Email Alerts
For All Stocks, ETFs, & Mutal Funds
- Zacks Memberships
Sign Up Free For Daily Alerts
Profit From The Pros With Zacks
- See The #1 Breakout Stock
Just Released
Stock Most Likely to Jump In Price
- Bear & Bull of the Day
Zacks Rank #1 Strong Buy & Sell
Average Yearly Gain of +24.3%
- Zacks Investment Research
Experts At Zacks List 5 Stocks That
Expect to Deliver Extreme Profits.
- Zacks #1 Rank
Search results
bluebird bio, Inc. (NASDAQ:BLUE) is favoured by institutional owners who hold 58% of the company
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in bluebird bio, Inc. (NASDAQ:BLUE) should be aware of the most powerful shareholder...
Will bluebird bio (NASDAQ:BLUE) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 1 year agoJust because a business does not make any money, does not mean that the stock will go down. For...
A Look At The Fair Value Of bluebird bio, Inc. (NASDAQ:BLUE)
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights The projected fair value for bluebird bio is US$3.38 based on 2 Stage Free Cash Flow to...
Why Bluebird Bio Stock Is Taking Flight Today
Motley Fool· 10 months agoWhat happened Shares of the commercial-stage gene therapy company bluebird bio (NASDAQ: BLUE) are having a strong session Wednesday. The biotech's stock...
Why Bluebird Bio Stock Soared 7% Higher on Tuesday
Motley Fool· 7 months agoThe company posted some encouraging numbers and said it had sufficient resources to take care of financial obligations through the second quarter of...
Here's Why bluebird bio (NASDAQ:BLUE) Must Use Its Cash Wisely
Simply Wall St. via Yahoo Finance· 7 months agoJust because a business does not make any money, does not mean that the stock will go down. For...
BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
TipRanks via Yahoo Finance· 2 weeks agoLast week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...
2 Biotech Stocks That Could Soar in December
Motley Fool· 6 months agoBiotech stocks have been struggling for more than two years. In December, Bluebird Bio (NASDAQ: BLUE) and Structure Therapeutics (NASDAQ: GPCR) both have...
These 2 Stocks Could Be About to Soar: Are They Buys?
Motley Fool· 6 months agoShares of relatively small biotech companies often soar when they get positive news from regulators,...
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
Motley Fool· 9 months agoInvestors looking for stocks that can put up dramatic gains in a short amount of time naturally...